Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Purpura, Thrombocytopenic, Autoimmune”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Not applicableStudy completedNCT04057703
What this trial is testing

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.

Who this might be right for
Immune Thrombocytopenic PurpuraAutoimmune Hemolytic AnemiaEvan Syndrome+1 more
University Hospital, Bordeaux 454
Not applicableLooking for participantsNCT06919341
What this trial is testing

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

Who this might be right for
ITP - Immune ThrombocytopeniaPrimary Immune Thrombocytopenia (ITP)
Fundación Española de Hematología y Hemoterapía 1,000
Large-scale testing (Phase 3)Study completedNCT03010202
What this trial is testing

The PROLONG Trial - Rituximab Maintenance Therapy in ITP

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Ostfold Hospital Trust 136
Not applicableNot Yet RecruitingNCT07798050
What this trial is testing

Selective Mediterranean Diet in Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraThrombocytopenia
Assiut University 60
Not applicableStudy completedNCT01672151
What this trial is testing

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Not applicableLooking for participantsNCT04890041
What this trial is testing

TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years

Who this might be right for
Primary Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Large-scale testing (Phase 3)UnknownNCT06004856
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd. 195
Large-scale testing (Phase 3)Study completedNCT02076412
What this trial is testing

A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 74
Not applicableLooking for participantsNCT07612319
What this trial is testing

Romiplostim for Oral TPO-RA Resistant ITP

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Testing effectiveness (Phase 2)UnknownNCT05124028
What this trial is testing

Orelabrutinib in Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01129024
What this trial is testing

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shionogi 19
Testing effectiveness (Phase 2)UnknownNCT05411874
What this trial is testing

Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP

Who this might be right for
Thrombocytopenia
Shandong University 100
Early research (Phase 1)Study completedNCT02281370
What this trial is testing

Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
GlaxoSmithKline 39
Post-approval studies (Phase 4)WithdrawnNCT02642380
What this trial is testing

Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shandong University
Post-approval studies (Phase 4)Study completedNCT01356511
What this trial is testing

High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Shandong University 261
Testing effectiveness (Phase 2)Looking for participantsNCT07063199
What this trial is testing

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Large-scale testing (Phase 3)UnknownNCT02270801
What this trial is testing

Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Shandong University 30
Next Page